Abstract

With the availability of authorized COVID-19 vaccines in early 2021, vaccination became an effective tool to reduce COVID-19-associated morbidity and mortality. Initially, the World Health Organization (WHO) set an ambitious target to vaccinate 70% of the global population by mid-2022. However, in July 2022, WHO recommended that all countries, including those in the African Region, prioritize COVID-19 vaccination of high-risk groups, including older adults and health care workers, to have the greatest impact on morbidity and mortality. As of December 31, 2023, approximately 860 million doses of COVID-19 vaccine had been delivered to countries in the African Region, and 646 million doses had been administered. Cumulatively, 38% of the African Region's population had received ≥1 dose, 32% had completed a primary series, and 21% had received ≥1 booster dose. Cumulative total population coverage with ≥1 dose ranged by country from 0.3% to 89%. Coverage with the primary series among older age groups was 52% (range among countries = 15%-96%); primary series coverage among health care workers was 48% (range = 13%-99%). Although the COVID-19 public health emergency of international concern was declared over in May 2023, current WHO recommendations reinforce the need to vaccinate priority populations at highest risk for severe COVID-19 disease and death and build more sustainable programs by integrating COVID-19 vaccination into primary health care, strengthening immunization across the life course, and improving pandemic preparedness.

MeSH

Mortality, Vaccines, Covid-19 Vaccines, Vaccination, Covid-19, Morbidity, Vaccination Coverage

Cited by

• Genome diversity of SARS-CoV-2 lineages associated with vaccination breakthrough infections in Addis Ababa, Ethiopia. BMC Infect Dis, 2025
• Association of gross domestic product with equitable access to childhood vaccines in 195 countries: a systematic review and meta-analysis. BMJ Glob Health, 2025
• COVID- 19 vaccine uptake and its determinants in Cameroon: a systematic review and meta-analysis (2021-2024). BMC Infect Dis, 2025
• Final COVID-19 Vaccination Status, Attitude, and Adverse Events Among People With Multiple Sclerosis: A Cross-Sectional Study From Egypt. Int J MS Care, 2025
• Global Status of Adult Immunization Post COVID-19 Pandemic. Vaccines (Basel), 2025
• Global Systematic Scoping Review of Adolescent Factors Associated With COVID-19 Vaccine Hesitancy. J Adolesc Health, 2025
• Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants. J Virol, 2025
• Completion of Multidose COVID-19 Vaccination Among Adolescents and Adults in Urban Informal Settlements in Nairobi, Kenya. Am J Trop Med Hyg, 2025
• Overcoming Vaccine Inequities and Research Gaps in Africa: Challenges and Opportunities Identified During the COVID-19 Pandemic. Clin Infect Dis, 2025